Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Rheumatoid Arthritis

  Free Subscription


Articles published in Z Rheumatol

Retrieve available abstracts of 100 articles:
HTML format



Single Articles


    July 2021
  1. SUNG YK, Lee YH
    Placebo and nocebo responses in randomized controlled trials of non-tumor necrosis factor biologics and Janus kinase inhibitors in patients with active rheumatoid arthritis showing insufficient response to tumor necrosis factor inhibitors: A meta-anal
    Z Rheumatol. 2021 Jul 9. pii: 10.1007/s00393-021-01047.
    PubMed     Abstract available


  2. LEE YH, Song GG
    Comparative efficacy and safety of infliximab and its biosimilars in patients with rheumatoid arthritis presenting an insufficient response to methotrexate : A network meta-analysis.
    Z Rheumatol. 2021 Jul 6. pii: 10.1007/s00393-021-01040.
    PubMed     Abstract available


  3. HO LEE Y, Gyu Song G
    Comparative efficacy and safety of tumor necrosis factor inhibitors and their biosimilars in patients with rheumatoid arthritis having an insufficient response to methotrexate : A network meta-analysis.
    Z Rheumatol. 2021 Jul 5. pii: 10.1007/s00393-021-01041.
    PubMed     Abstract available


    June 2021
  4. CHRISTENN M
    [Immunogenicity and safety of high dose vs. standard dose of inactivated influenza vaccine in patients with rheumatoid arthritis].
    Z Rheumatol. 2021 Jun 25. pii: 10.1007/s00393-021-01030.
    PubMed    


  5. VALOR-MENDEZ L, Manger B, Schett G, Kleyer A, et al
    [Severe Hepatitis E virus infection in a patient with rheumatoid arthritis treated with baricitinib].
    Z Rheumatol. 2021 Jun 7. pii: 10.1007/s00393-021-01020.
    PubMed     Abstract available


  6. SIEROCINSKI E, Angelow A, Mainz A, Walker J, et al
    [Patient safety in the treatment of rheumatic diseases : Laboratory monitoring in methotrexate treatment].
    Z Rheumatol. 2021;80:418-424.
    PubMed     Abstract available


    May 2021
  7. LEE YH, Song GG
    Comparative efficacy and safety of adalimumab biosimilars and adalimumab in patients with rheumatoid arthritis presenting an insufficient response to methotrexate: a network meta-analysis.
    Z Rheumatol. 2021 May 17. pii: 10.1007/s00393-021-01013.
    PubMed     Abstract available


    April 2021
  8. ARTZT B, Arndt M, Wickler B, Rehart S, et al
    [Gigantic prepatellar "tumor" in rheumatoid arthritis-a case report].
    Z Rheumatol. 2021 Apr 30. pii: 10.1007/s00393-021-01010.
    PubMed     Abstract available


  9. ALBRECHT K, Zink A
    [If smoking, then also drinking? : New aspects on the influence of alcohol and smoking on the risk for rheumatoid arthritis].
    Z Rheumatol. 2021 Apr 20. pii: 10.1007/s00393-021-01004.
    PubMed    


  10. HARTUNG W, Sewerin P, Ostendorf B
    [Sports and exercise therapy in inflammatory rheumatic diseases].
    Z Rheumatol. 2021;80:251-262.
    PubMed     Abstract available


    March 2021
  11. KEYSSER G
    [Safety aspects of the treatment with glucocorticoids for rheumatoid arthritis].
    Z Rheumatol. 2021 Mar 11. pii: 10.1007/s00393-021-00972.
    PubMed     Abstract available


  12. FIEHN C
    [Glucocorticoid-free and low-dose glucocorticoid treatment of rheumatoid arthritis].
    Z Rheumatol. 2021 Mar 10. pii: 10.1007/s00393-021-00973.
    PubMed     Abstract available


  13. SUNG YK, Lee YH
    Placebo and nocebo responses in randomized controlled trials of Janus kinase inhibitor monotherapy for rheumatoid arthritis : A meta-analysis.
    Z Rheumatol. 2021 Mar 9. pii: 10.1007/s00393-021-00969.
    PubMed     Abstract available


    December 2020
  14. CHEN LJ, Zhou YJ, Wen ZH, Tian F, et al
    Efficacy and safety of iguratimod combined with methotrexate vs. methotrexate alone in rheumatoid arthritis : A systematic review and meta-analysis of randomized controlled trials.
    Z Rheumatol. 2020 Dec 21. pii: 10.1007/s00393-020-00944.
    PubMed     Abstract available


  15. MEISSNER Y, Milatz F, Callhoff J, Minden K, et al
    [Register and cohort studies : Overview of the most important data sources at the German Rheumatism Research Center].
    Z Rheumatol. 2020;79:983-995.
    PubMed     Abstract available


  16. HOFF P, Walther M, Wesselmann H, Weinerth J, et al
    [Successful treatment of adult Still's disease with tofacitinib in a HIV-2 positive female patient].
    Z Rheumatol. 2020;79:1046-1049.
    PubMed     Abstract available


  17. BUEHRING B, Thomas J, Wittkamper T, Baraliakos X, et al
    [Evaluation of the trabecular bone score (TBS) in routine clinical care of patients with inflammatory rheumatic and non-inflammatory diseases : Correlation with conventional bone mineral density measurement and prevalence of vertebral fractures].
    Z Rheumatol. 2020;79:1067-1074.
    PubMed     Abstract available


    November 2020
  18. JAGER E
    [Calcium, phosphate and the calcium-sensing receptor : A proinflammatory combination in rheumatoid arthritis].
    Z Rheumatol. 2020 Nov 30. pii: 10.1007/s00393-020-00937.
    PubMed     Abstract available


  19. SCHERER HU
    [Autoantibodies and the autoreactive immune response : There is more to ACPA than ACPA].
    Z Rheumatol. 2020;79:893-897.
    PubMed     Abstract available


    October 2020
  20. ABDA EA, Hassanien MM, Abdelrazek E, Mahran SA, et al
    What can hand sonography and nerve conduction velocity disclose regarding hand dysfunction in rheumatoid arthritis patients?
    Z Rheumatol. 2020 Oct 2. pii: 10.1007/s00393-020-00901.
    PubMed     Abstract available


    September 2020
  21. SAAD RB, Fazaa A, Rouached L, Miladi S, et al
    Sexual dysfunction and its determinants in women with rheumatoid arthritis.
    Z Rheumatol. 2020 Sep 29. pii: 10.1007/s00393-020-00890.
    PubMed     Abstract available


  22. SUNG YK, Lee YH
    Comparative study of the efficacy and safety of tofacitinib, baricitinib, upadacitinib, and filgotinib versus methotrexate for disease-modifying antirheumatic drug-naive patients with rheumatoid arthritis.
    Z Rheumatol. 2020 Sep 24. pii: 10.1007/s00393-020-00889.
    PubMed     Abstract available


  23. SCHWARZE M, Fieguth V, Schuch F, Sandner P, et al
    [Disease-related knowledge acquisition through structured patient information in rheumatoid arthritis (StruPI-RA) : First results of the StruPI-RA study in Germany].
    Z Rheumatol. 2020 Sep 14. pii: 10.1007/s00393-020-00871.
    PubMed     Abstract available


  24. THIELE T, Seeliger T, Witte T, Sander B, et al
    [Severe polyneuropathy in primary Sjogren's syndrome : Sjogren's syndrome should be considered in patients with motor neuropathy].
    Z Rheumatol. 2020;79:707-709.
    PubMed     Abstract available


  25. FOLL D, Wittkowski H, Hinze C
    [Still's disease as biphasic disorder : Current knowledge on pathogenesis and novel treatment approaches].
    Z Rheumatol. 2020;79:639-648.
    PubMed     Abstract available


    August 2020
  26. STEINCHEN N, Muller-Ladner U, Lange U
    [Biological therapy after COVID-19 infection : No reactivation of a COVID-19 infection with positive SARS-CoV-2 antibody status under biological therapy].
    Z Rheumatol. 2020;79:574-577.
    PubMed     Abstract available


  27. WITTE T
    [Longstanding Sjogren's syndrome without heightened risk of lymphoma].
    Z Rheumatol. 2020;79:571-573.
    PubMed    


    June 2020
  28. BEIDER S, Flohr S, Gehlert S, Witte T, et al
    [Association of physical activity with fatigue and functional capacity in patients with rheumatoid arthritis].
    Z Rheumatol. 2020 Jun 25. pii: 10.1007/s00393-020-00830.
    PubMed     Abstract available


  29. SCHNEIDER M, Baseler G, Funken O, Heberger S, et al
    [Management of early rheumatoid arthritis : Interdisciplinary guideline].
    Z Rheumatol. 2020;79.
    PubMed    


    May 2020
  30. BLUML S
    [Erratum to: Biologicals and small molecules for rheumatoid arthritis].
    Z Rheumatol. 2020 May 15. pii: 10.1007/s00393-020-00817.
    PubMed    


  31. LEE YH, Song GG
    Comparative efficacy and safety of tofacitinib, baricitinib, upadacitinib, and filgotinib in active rheumatoid arthritis refractory to biologic disease-modifying antirheumatic drugs.
    Z Rheumatol. 2020 May 4. pii: 10.1007/s00393-020-00796.
    PubMed     Abstract available


  32. HOYER BF
    [New treatments for systemic lupus erythematosus].
    Z Rheumatol. 2020;79:342-350.
    PubMed     Abstract available


  33. MUCKE J, Dusing C, Chehab G, Schneider M, et al
    [Treat to target in systemic lupus erythematosus].
    Z Rheumatol. 2020;79:351-358.
    PubMed     Abstract available


    April 2020
  34. ALTEN R, Mischkewitz M, Stefanski AL, Dorner T, et al
    [Janus kinase inhibitors : State of the art in clinical use and future perspectives].
    Z Rheumatol. 2020;79:241-254.
    PubMed     Abstract available


    March 2020
  35. GERLICH C, Andreica I, Kuffner R, Krause D, et al
    [Evaluation of a basic educational program for patients with rheumatoid arthritis].
    Z Rheumatol. 2020 Mar 16. pii: 10.1007/s00393-020-00769.
    PubMed     Abstract available


  36. BLUML S
    [Biologicals and small molecules for rheumatoid arthritis].
    Z Rheumatol. 2020 Mar 16. pii: 10.1007/s00393-020-00766.
    PubMed     Abstract available


  37. KIM Y, Kim GT, Lee SG, Lee HN, et al
    First Asian case of biopsy-confirmed manubriosternal joint involvement in rheumatoid arthritis.
    Z Rheumatol. 2020 Mar 5. pii: 10.1007/s00393-020-00763.
    PubMed     Abstract available


    February 2020
  38. LEE YH, Song GG
    Relative efficacy and safety of tofacitinib, baricitinib, upadacitinib, and filgotinib in comparison to adalimumab in patients with active rheumatoid arthritis.
    Z Rheumatol. 2020 Feb 13. pii: 10.1007/s00393-020-00750.
    PubMed     Abstract available


  39. REUSCH A, Braun J, Lakomek HJ, Lakomek M, et al
    [Flexible programs and advanced training for rheumatological patient education].
    Z Rheumatol. 2020;79:74-77.
    PubMed     Abstract available


  40. KOHM M, Behrens F
    [Treatment of psoriatic arthritis : Are there differential indications?]
    Z Rheumatol. 2020;79:23-32.
    PubMed     Abstract available


    January 2020
  41. BAE SC, Lee YH
    Causal association between periodontitis and risk of rheumatoid arthritis and systemic lupus erythematosus: a Mendelian randomization.
    Z Rheumatol. 2020 Jan 21. pii: 10.1007/s00393-019-00742.
    PubMed     Abstract available


    December 2019
  42. ALBRECHT K, Callhoff J, Zink A
    Long-term trends in rheumatology care : Achievements and deficits in 25 years of the German national rheumatology database.
    Z Rheumatol. 2019;78.
    PubMed     Abstract available


  43. CALLHOFF J, Albrecht K, Hoffmann F, Poddubnyy D, et al
    Reality of care for musculoskeletal diseases at the population level : Results of the PROCLAIR collaborative project.
    Z Rheumatol. 2019;78.
    PubMed     Abstract available


    November 2019
  44. LEE YH, Song GG
    Comparison of the efficacy and safety of tofacitinib and filgotinib in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials.
    Z Rheumatol. 2019 Nov 28. pii: 10.1007/s00393-019-00733.
    PubMed     Abstract available


  45. FREIER D, Englbrecht M, Hohne-Zimmer V, Detert J, et al
    [Higher prevalence of depressive and anxiety symptoms in early arthritis patients in comparison to the normal population].
    Z Rheumatol. 2019;78:820-831.
    PubMed     Abstract available


  46. FINSTERER J, Melichart-Kotig M, Woehrer A
    Mitochondrial disorder mimicking rheumatoid disease.
    Z Rheumatol. 2019;78:875-880.
    PubMed     Abstract available




  47. Z Rheumatol. 2019;78:810-812.
    PubMed    


    October 2019
  48. FREIER D, Strehl C, Buttgereit F
    [Oral glucocorticoids : Therapeutic use and treatment monitoring in inflammatory rheumatic diseases].
    Z Rheumatol. 2019;78:775-788.
    PubMed     Abstract available


  49. SCHWARTING A, Dreher M, Assmann G, Witte T, et al
    [Experiences and results from Rheuma-VOR].
    Z Rheumatol. 2019;78:743-752.
    PubMed     Abstract available


  50. ALBRECHT K, Callhoff J, Zink A
    [Long-term trends in rheumatology care : Achievements and deficits in 25 years of the German national rheumatology database].
    Z Rheumatol. 2019;78:703-712.
    PubMed     Abstract available


  51. CALLHOFF J, Albrecht K, Hoffmann F, Poddubnyy D, et al
    [Reality of care for musculoskeletal diseases at the population level : Results of the PROCLAIR collaborative project. German version].
    Z Rheumatol. 2019;78:713-721.
    PubMed     Abstract available


    September 2019
  52. THIELE K, Callhoff J, Eidner T, Hoese G, et al
    [Which patients with rheumatoid arthritis do not receive DMARD treatment? Analysis of data from the German Collaborative Arthritis Centers].
    Z Rheumatol. 2019 Sep 11. pii: 10.1007/s00393-019-00712.
    PubMed     Abstract available


    August 2019
  53. BAE SC, Lee YH
    Association between plasminogen activator inhibitor1 (PAI-1) 4G/5G polymorphism and circulating PAI-1 level in systemic lupus erythematosus and rheumatoid arthritis : A meta-analysis.
    Z Rheumatol. 2019 Aug 19. pii: 10.1007/s00393-019-00689.
    PubMed     Abstract available


  54. WITTE T
    [Sjogren's syndrome].
    Z Rheumatol. 2019;78:511-517.
    PubMed     Abstract available


    July 2019
  55. SCHLIEKER R, Keysser G
    [Establishment of the current classification criteria for axial spondylarthritis, rheumatoid arthritis and SLE in routine practice of German rheumatologists].
    Z Rheumatol. 2019 Jul 25. pii: 10.1007/s00393-019-0677.
    PubMed     Abstract available


  56. FIEHN C, Kruger K
    [Treatment algorithm for rheumatoid arthritis : According to the S2e guidelines 2018].
    Z Rheumatol. 2019 Jul 11. pii: 10.1007/s00393-019-0668.
    PubMed     Abstract available


    June 2019
  57. LAUTER A, Triantafyllias K, Leiss R, Amberger C, et al
    [ADAPTHERA-Statewide cross-sectoral care network for patients with early rheumatoid arthritis shows sustained remission in standard care].
    Z Rheumatol. 2019 Jun 4. pii: 10.1007/s00393-019-0653.
    PubMed     Abstract available


  58. EDELMANN E, Schuch F, Kalthoff L, Zinke S, et al
    [Special treatment in rheumatology-cross-sectoral quality-oriented selective contracts].
    Z Rheumatol. 2019;78:429-438.
    PubMed     Abstract available


  59. LORENZ HM, Wendler J, Krause A
    [Improvement of prognosis by timely treatment : Requirement: initial presentation within 6 weeks].
    Z Rheumatol. 2019;78:396-403.
    PubMed     Abstract available


    May 2019
  60. KRUGER K, Kneitz C
    [Comorbidities-Their role in the treat to target concept for rheumatoid arthritis].
    Z Rheumatol. 2019 May 2. pii: 10.1007/s00393-019-0637.
    PubMed     Abstract available


    April 2019
  61. TRIANTAFYLLIAS K, Leiss R, Dreher M, Schwarting A, et al
    [Depressive symptoms in early rheumatoid arthritis : Within the rheumatism network ADAPTHERA].
    Z Rheumatol. 2019 Apr 23. pii: 10.1007/s00393-019-0596.
    PubMed     Abstract available


  62. SCHNEIDER M, Burmester GR
    [Tight control-Demand for short term control of rheumatoid arthritis].
    Z Rheumatol. 2019 Apr 18. pii: 10.1007/s00393-019-0631.
    PubMed     Abstract available


  63. FIEHN C
    [Why we recommend parenteral methotrexate for the treatment of rheumatoid arthritis: a response and overview of the literature].
    Z Rheumatol. 2019 Apr 2. pii: 10.1007/s00393-019-0628.
    PubMed    


  64. HARTEN P
    [Further evidence necessary for initial subcutaneous administration of MTX in the treatment of rheumatoid arthritis].
    Z Rheumatol. 2019 Apr 2. pii: 10.1007/s00393-019-0624.
    PubMed    


    March 2019
  65. KRAUSE A, Rubbert-Roth A
    [Pulmonary involvement in rheumatoid arthritis].
    Z Rheumatol. 2019 Mar 18. pii: 10.1007/s00393-019-0611.
    PubMed     Abstract available


  66. KRUSCHE M, Boro D, Bertolini J, Kotter I, et al
    [Rare erosive arthritis and dermatitis syndrome in Whipple's disease].
    Z Rheumatol. 2019;78:180-182.
    PubMed     Abstract available


  67. DISCHEREIT G, Goronzy JE, Muller-Ladner U, Fetaj S, et al
    [Effects of serial mud baths on inflammatory rheumatic and degenerative diseases].
    Z Rheumatol. 2019;78:143-154.
    PubMed     Abstract available


    February 2019
  68. SONG GG, Lee YH
    Comparative efficacy and safety of 15 and 30mg upadacitinib administered to patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials.
    Z Rheumatol. 2019 Feb 6. pii: 10.1007/s00393-019-0601.
    PubMed     Abstract available


  69. KLEMM P, Hudowenz O, Asendorf T, Muller-Ladner U, et al
    [Multimodal rheumatologic complex treatment of rheumatoid arthritis-a monocentric retrospective analysis].
    Z Rheumatol. 2019 Feb 4. pii: 10.1007/s00393-019-0593.
    PubMed     Abstract available


    January 2019
  70. GAUBITZ M, Lippe R, Gottl KH, Luthke K, et al
    [Etanercept in routine German clinical practice to treat rheumatoid arthritis patients : A one-year observational study on effectiveness, safety and health economics].
    Z Rheumatol. 2019 Jan 25. pii: 10.1007/s00393-018-0536.
    PubMed     Abstract available


  71. KRUGER K, Nusslein H
    [Cardiovascular comorbidities in rheumatoid arthritis].
    Z Rheumatol. 2019 Jan 17. pii: 10.1007/s00393-018-0584.
    PubMed     Abstract available


    November 2018
  72. BAERWALD C, Manger B, Hueber A
    [Depression as comorbidity of rheumatoid arthritis].
    Z Rheumatol. 2018 Nov 28. pii: 10.1007/s00393-018-0568.
    PubMed     Abstract available


  73. JACOBS H, Callhoff J, Hoffmann F, Zink A, et al
    [Non-drug treatment of rheumatoid arthritis : An analysis of claims data and a survey of insured persons (Project PROCLAIR)].
    Z Rheumatol. 2018 Nov 26. pii: 10.1007/s00393-018-0567.
    PubMed     Abstract available


  74. ZHANG Q, Yuan R, Li C, Wei W, et al
    Macrophage depletion with clodronate-containing liposomes affects the incidence and development of rheumatoid arthritis.
    Z Rheumatol. 2018 Nov 26. pii: 10.1007/s00393-018-0563.
    PubMed     Abstract available


  75. JANSSEN I, Shiban E, Meyer B
    [Cervical spine involvement in rheumatoid arthritis : Diagnostics and treatment of instability due to rheumatism].
    Z Rheumatol. 2018 Nov 12. pii: 10.1007/s00393-018-0564.
    PubMed     Abstract available


    October 2018
  76. KRAUSE A, Aries PM, Berger S, Fiehn C, et al
    Rituximab in routine care of severe active rheumatoid arthritis : A prospective, non-interventional study in Germany.
    Z Rheumatol. 2018 Oct 1. pii: 10.1007/s00393-018-0552.
    PubMed     Abstract available


    September 2018
  77. BAE SC, Lee YH
    Alcohol intake and risk of rheumatoid arthritis: a Mendelian randomization study.
    Z Rheumatol. 2018 Sep 12. pii: 10.1007/s00393-018-0537.
    PubMed     Abstract available


  78. MADERBACHER G, Greimel F, Schaumburger J, Grifka J, et al
    [The knee joint in rheumatoid arthritis-current orthopaedic surgical treatment options].
    Z Rheumatol. 2018 Sep 7. pii: 10.1007/s00393-018-0534.
    PubMed     Abstract available


  79. BAE SC, Lee YH
    Comparison of the efficacy and safety of tofacitinib and baricitinib in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials.
    Z Rheumatol. 2018 Sep 6. pii: 10.1007/s00393-018-0531.
    PubMed     Abstract available


  80. BASTIAN H, Ziegeler K, Hermann KGA, Feist E, et al
    [Rheumatoid arthritis-mimics : When appearances are deceptive].
    Z Rheumatol. 2018 Sep 6. pii: 10.1007/s00393-018-0527.
    PubMed     Abstract available


    August 2018
  81. LAU YN, Ng J, Lee SY, Li LC, et al
    A brief report on the clinical trial on neural mobilization exercise for joint pain in patients with rheumatoid arthritis.
    Z Rheumatol. 2018 Aug 15. pii: 10.1007/s00393-018-0521.
    PubMed     Abstract available


    July 2018
  82. BAE SC, Lee YH
    Causal association between rheumatoid arthritis and a decreased risk of Alzheimer's disease : A Mendelian randomization study.
    Z Rheumatol. 2018 Jul 5. pii: 10.1007/s00393-018-0504.
    PubMed     Abstract available


  83. NEUMANN E, Frommer K, Diller M, Muller-Ladner U, et al
    [Rheumatoid arthritis].
    Z Rheumatol. 2018 Jul 5. pii: 10.1007/s00393-018-0500.
    PubMed     Abstract available


  84. FIEHN C, Holle J, Iking-Konert C, Leipe J, et al
    [S2e guideline: treatment of rheumatoid arthritis with disease-modifying drugs].
    Z Rheumatol. 2018 Jul 3. pii: 10.1007/s00393-018-0481.
    PubMed     Abstract available


    May 2018
  85. OSTOJIC P, Pavlov-Dolijanovic S
    Alopecia universalis in a patient with rheumatoid arthritis developed during treatment with adalimumab.
    Z Rheumatol. 2018 May 9. pii: 10.1007/s00393-018-0464.
    PubMed     Abstract available


    April 2018
  86. BAUHAMMER J, Fiehn C
    [Getting older with rheumatoid arthritis-is there a burnout of the disease?]
    Z Rheumatol. 2018 Apr 30. pii: 10.1007/s00393-018-0465.
    PubMed     Abstract available


  87. HAUPL T, Skapenko A, Hoppe B, Skriner K, et al
    [Biomarkers and imaging for diagnosis and stratification of rheumatoid arthritis and spondylarthritis in the BMBF consortium ArthroMark].
    Z Rheumatol. 2018 Apr 24. pii: 10.1007/s00393-018-0458.
    PubMed     Abstract available


  88. KUIPERS JG, Koller M, Zeman F, Muller K, et al
    Adherence and health literacy as related to outcome of patients treated for rheumatoid arthritis : Analyses of a large-scale observational study.
    Z Rheumatol. 2018 Apr 24. pii: 10.1007/s00393-018-0449.
    PubMed     Abstract available


  89. TURGAY YILDIRIM O, Gonullu E, Aydin F, Aksit E, et al
    Nocturnal blood pressure dipping is similar in rheumatoid arthritis patients as compared to a normal population.
    Z Rheumatol. 2018 Apr 12. pii: 10.1007/s00393-018-0451.
    PubMed     Abstract available


    February 2018
  90. LIU Y, Wen H
    Impact of vitamin D deficiency on clinical parameters in treatment-naive rheumatoid arthritis patients.
    Z Rheumatol. 2018 Feb 19. pii: 10.1007/s00393-018-0426.
    PubMed     Abstract available


    January 2018
  91. BAE SC, Lee YH
    TYMS polymorphisms and responsiveness to or toxicity of methotrexate in rheumatoid arthritis.
    Z Rheumatol. 2018 Jan 29. pii: 10.1007/s00393-018-0419.
    PubMed     Abstract available


    September 2017
  92. STRAHL A, Schneider O, Frankenhauser-Mannuss J, Knapstein S, et al
    [Prevalence, comorbidity and interdisciplinary treatment of rheumatoid arthritis - Insurance data on outpatient and inpatient care in Baden-Wurttemberg].
    Z Rheumatol. 2017 Sep 19. doi: 10.1007/s00393-017-0381.
    PubMed     Abstract available


  93. KOTHE R
    [Low back pain in rheumatoid arthritis].
    Z Rheumatol. 2017 Sep 5. doi: 10.1007/s00393-017-0363.
    PubMed     Abstract available


    August 2017
  94. KOTTER I, Stubiger N, Deuter C
    [Ocular involvement in rheumatoid arthritis, connective tissue diseases and vasculitis].
    Z Rheumatol. 2017 Aug 31. doi: 10.1007/s00393-017-0372.
    PubMed     Abstract available


  95. STROBEL S, Rossol M
    [Monocyte subpopulations in patients with rheumatoid arthritis].
    Z Rheumatol. 2017 Aug 3. doi: 10.1007/s00393-017-0352.
    PubMed    


    May 2017
  96. BAE SC, Lee YH
    Association between anti-Porphyromonas gingivalis antibody, anti-citrullinated protein antibodies, and rheumatoid arthritis : A meta-analysis.
    Z Rheumatol. 2017 May 29. doi: 10.1007/s00393-017-0328.
    PubMed     Abstract available


    April 2017
  97. KEYSSER G
    [Success for a new generation of disease-modifying antirheumatic drugs : The Janus kinase inhibitor baricitinib in rheumatoid arthritis].
    Z Rheumatol. 2017 Apr 26. doi: 10.1007/s00393-017-0307.
    PubMed    


  98. ALBRECHT K, Richter A, Meissner Y, Huscher D, et al
    [How frequent are poor prognostic markers in rheumatoid arthritis? : An estimate based on three epidemiologic cohorts].
    Z Rheumatol. 2017 Apr 20. doi: 10.1007/s00393-017-0306.
    PubMed     Abstract available


    March 2017
  99. ALBRECHT K, Luque Ramos A, Callhoff J, Hoffmann F, et al
    [Outpatient care and disease burden of rheumatoid arthritis : Results of a linkage of claims data and a survey of insured persons].
    Z Rheumatol. 2017 Mar 21. doi: 10.1007/s00393-017-0294.
    PubMed     Abstract available


  100. BAE SC, Lee YH
    Comparative efficacy and tolerability of sarilumab 150 and 200 mg in patients with active rheumatoid arthritis : A Bayesian network meta-analysis of randomized controlled trials.
    Z Rheumatol. 2017 Mar 21. doi: 10.1007/s00393-017-0292.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: